Skip to content
Helixer Medical logo

About us

We are developing MR software using patented techniques to track and visualize device and tissue in 3D and real-time to improve health outcomes and reduce procedure times. Our technology is vendor agnostic, such that it will work with any combination of MRI and MR-compatible device. The beachhead market we are targeting is ventricular tachycardia as that is our group’s expertise and the market is not as saturated compared to other markets. After we prove the efficacy of our software, we will branch out to other indications, like atrial fibrillation, intracardiac tissue drug delivery, and cancer biopsy/target treatments.

Program engagement

Helixir Medical

Leadership

Moses Cook

Founder & CEO

Jaykumar Patel

Founder & CTO

Daniel Djayakarsana

Founder & COO

Status

Intellectual Property

Fundraising

Sector

Subsector

i.d.e.a. Fund Applications Open

Applications are now open for i.d.e.a. Fund Cohort 4

Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?

The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.

Applications are open from June 16 to July 7, 2025.